Medication Engagement Reward Initiative, Inc. – Trademark Portfolio
Entity Type: 03
Medication Engagement Reward Initiative, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MERI and WELLNICHE. The owner is based in Charlotte, NC.
Apt. 101
1612 Galleria Club Ln.
Charlotte, NC 28270
Showing of trademarks Trademarks
Trademark Classifications
Medication Engagement Reward Initiative, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Medication Engagement Reward Initiative, Inc. have?
Medication Engagement Reward Initiative, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Medication Engagement Reward Initiative, Inc. file in?
Medication Engagement Reward Initiative, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Medication Engagement Reward Initiative, Inc.'s most well-known trademarks?
Medication Engagement Reward Initiative, Inc.'s registered trademark portfolio includes well-known marks such as MERI and WELLNICHE. These are among 2 currently registered trademarks in the portfolio.
What is Medication Engagement Reward Initiative, Inc.'s trademark registration success rate?
Medication Engagement Reward Initiative, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.